The Sterile Injectables CDMO Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Sterile Injectables CDMO Market?
The market size for the Sterile Injectables CDMO has seen fast growth in the recent past. It is projected to increase from $6.01 billion in 2024 to $6.65 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Sterile Injectables CDMO Industry?
The Sterile Injectables CDMO Global Market is expected to reach $9.89 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%.
Download Your Free Sample of the 2025 Sterile Injectables CDMO Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Sterile Injectables CDMO Market?
The key drivers in the sterile injectables cdmo market are:
• Rising demand for biologics and biosimilars
• The prevalence of chronic and complex health conditions leading to an increased need for more targeted treatments
• Higher reliance on sterile injectable CDMO services due to the method of administration of these treatments
• Stringent requirements for maintaining sterile conditions for safety, quality, and regulatory compliance
Global Market Segmentation: Identifying Major Sterile Injectables CDMO Industry Segments
The sterile injectables cdmo market covered in this report is segmented –
1) By Type: Small Molecule, Large Molecule
2) By Service: Formulation Development, Analytical And Testing Services, Manufacturing, Packaging, Storage, Other Services
3) By Route Of Administration: Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Other Routes Of Administration
4) By Therapeutic Area: Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Disorders, Musculoskeletal Diseases, Hormonal Diseases, Other Therapeutic Areas
5) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Research Institutes, Other End-Users
Pre-order the 2025 Sterile Injectables CDMO Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Sterile Injectables CDMO Market?
The key trends in the sterile injectables cdmo market are:
• Trend towards using automated aseptic filling systems to enhance sterility assurance and decrease human intervention.
• Development of novel technologies like robotic technology in sterile product manufacturing.
• Increasing compatibility of systems with various injectable containers and global regulatory standards.
• Minimizing manual handling to maintain sterility and reduce potential contamination in the production process.
Who Are the Top Competitors & Leading Players in the Sterile Injectables CDMO Market?
Major players in the sterile injectables cdmo market are:
• Pfizer Inc.
• Thermo Fisher Scientific Inc.
• Boehringer Ingelheim
• Fresenius Kabi AG
• Lonza Group Ltd.
• Catalent Inc.
• Samsung Biologics Co. Ltd.
• Fareva SA
• Recipharm AB
• PCI Pharma Services
• Vetter Pharma
• Delpharm
• Kindeva Drug Delivery LP
• Ajinomoto Bio-Pharma Services
• Cenexi
• Grand River Aseptic Manufacturing Inc.
• INCOG BioPharma Services
• Aurigene Pharmaceutical Services
• Jubilant HollisterStier LLC
• Symbiosis Pharmaceutical Services Ltd.
• Afton Scientific Corp.
• Amaran Biotechnology Inc.
Regional Dominance: Which Area Leads the Global Sterile Injectables CDMO Market?
North America was the largest region in the sterile injectables CDMO market in 2024
